Search Orphan Drug Designations and Approvals
-
Generic Name: | eltoprazine HCl |
---|---|
Date Designated: | 02/08/2016 |
Orphan Designation: | Treatment of levodopa-induced dyskinesia associated with Parkinson's disease. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Amarantus BioScience Holdings, Inc. 655 Montgomery St. Suite 900 San Francisco, California 94111 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-